Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1

Status

Unknown 4Terminated 3Recruiting 3Not yet recruiting 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 72Lung Neoplasms 9Adenocarcinoma of Lung 7Brain Neoplasms 5Non-squamous Non-small Cell Lung Cancer 4NSCLC 4Adenocarcinoma 4Mesothelioma, Malignant 3Colorectal Neoplasms 3Nonsquamous Non-Small Cell Lung Cancer 2Non-squamous Cell Non-Small Cell Lung Cancer 2Neoplasms 2Meningeal Carcinomatosis 2Lymphoma 2Glioma 2Central Nervous System Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Untreated Advanced Non-Small Cell Lung Cancer 1Unresectable Stage III NSCLC 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thoracic Neoplasms 1Stomach Neoplasms 1Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer 1Staging IV NSCLC 1Squamous Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Respiratory Tract Neoplasms 1

Interventions

Gefitinib 5icotinib 4Pemetrexed 4Docetaxel 4camrelizumab 3apatinib 3anlotinib 3aflutinib 3Erlotinib Hydrochloride 3osimertinib 2dacomitinib 2Thalidomide 2Radiosurgery 2Drug Therapy 2Carboplatin 2Afatinib 2trilaciclib 1spartalizumab 1pembrolizumab 1nimotuzumab 1famitinib 1envafolimab 1Vinorelbine 1Tyrosine Kinase Inhibitors 1S 1 (combination) 1Radiofrequency Ablation 1Microphysiological Systems 1Immune Checkpoint Inhibitors 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × NSCLC × Pemetrexed × Clear all
NCT06332287 2024-03-27

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis

Jiangsu Province Nanjing Brain Hospital

Phase 2 Unknown
25 enrolled
Thoracic

NSCLC

NCT05209256 2022-01-26

Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC

The First Affiliated Hospital of Henan University of Science and Technology

Phase 2/3 Unknown
90 enrolled
Thoracic

NSCLC

NCT03269162 2017-09-14

Postoperative NSCLC Treated With Integrated Medicine Base on Circulating Tumor Cell Detection

Shanghai University of Traditional Chinese Medicine

Phase 3 Unknown
144 enrolled
Thoracic

NSCLC

NCT02631460 2015-12-16

S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC

Sun Yat-sen University

Phase 2 Unknown
470 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡